Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Latest filing published 08 Jul 2026 for Werewolf Therapeutics, Inc., €10k. Read the official filing
Filing timeline
BuySaleLuke Evnin
Insider track record
Disclosed buys
0
Disclosed sells
31
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Luke Evnin: trading record in brief
Luke Evnin is a declared insider of Werewolf Therapeutics, Inc. (senior executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 4 May 2021 to 7 July 2026, the count stands at 33 filings.
Every open-market trade on record is a sale: 31 sales worth €863k. No amount is published for 3 filings, which the totals therefore leave out. Outside the open market, there are 1 share grant. In 2026 alone, the filings show no purchases and 18 sales.
The latest filing, published on 8 July 2026, reports an open-market sale of €10k in Werewolf Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Luke Evnin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations33 total
35,770 shares@ US$0.320.069% mcap4.1% of flowCommon StockSEC:0001134657-26-000020:0
107,429 shares@ US$0.310.20% mcap11.8% of flowCommon StockSEC:0001134657-26-000020:1
157,084 sharesCommon StockSEC:0001134657-26-000019:0
76,928 sharesCommon StockSEC:0001134657-26-000018:0
20,072 shares@ US$0.440.042% mcap10.1% of flowCommon StockSEC:0001134657-26-000017:0
24,946 shares@ US$0.400.047% mcap11.4% of flowCommon StockSEC:0001134657-26-000017:1
60,547 sharesCommon StockSEC:0001134657-26-000017:2
80,852 shares@ US$0.480.15% mcap56.2% of flowCommon StockSEC:0001134657-26-000015:0
27,698 shares@ US$0.460.050% mcap18.5% of flowCommon StockSEC:0001134657-26-000015:1
32,556 shares@ US$0.450.058% mcap21.3% of flowCommon StockSEC:0001134657-26-000015:2
53,940 shares@ US$0.850.27% mcap18.9% of flowCommon StockSEC:0001134657-26-000007:0
95,412 shares@ US$0.730.41% mcap28.7% of flowCommon StockSEC:0001134657-26-000007:1
56,559 shares@ US$0.690.23% mcap16.1% of flowCommon StockSEC:0001134657-26-000007:2
38,782 shares@ US$0.542.1% of flowCommon StockSEC:0001134657-26-000006:0
43,198 shares@ US$0.552.4% of flowCommon StockSEC:0001134657-26-000005:0
7,716 shares@ US$0.630.5% of flowCommon StockSEC:0001134657-26-000004:0
18,378 shares@ US$0.641.2% of flowCommon StockSEC:0001134657-26-000002:0
34,847 shares@ US$0.612.1% of flowCommon StockSEC:0001134657-26-000001:0
59,307 shares@ US$0.694.4% of flowCommon StockSEC:0001134657-25-000018:0
23,640 shares@ US$1.072.8% of flowCommon StockSEC:0001134657-25-000017:0
37,104 shares@ US$1.064.6% of flowCommon StockSEC:0001134657-25-000016:0
16,568 shares@ US$0.972.0% of flowCommon StockSEC:0001134657-25-000015:0
38,043 shares@ US$0.894.1% of flowCommon StockSEC:0001134657-25-000014:0
38,978 shares@ US$0.985.0% of flowCommon StockSEC:0001134657-25-000013:0
41,287 shares@ US$0.834.7% of flowCommon StockSEC:0001134657-25-000012:0
25 of 33 declarations
